Leaflet OLMETEC 40mg film-coated tablets


Indicated for: hypertension

Substance: olmesartan medoxomil (antihypertensive)

ATC: C09CA08 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)

Olmesartan medoxomil is an angiotensin II receptor antagonist used for the treatment of hypertension. It works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, thereby lowering blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, headaches, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or hyperkalemia may occur. Patients should be informed of these risks before starting treatment.

General data about OLMETEC 40mg

  • Substance: olmesartan medoxomil
  • Date of last drug list: 01-05-2026
  • Commercial code: W65767002
  • Concentration: 40mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: original
  • Price: 49.79 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: DAIICHI SANKYO EUROPE GMBH - GERMANIA
  • Holder: ALVOGEN PHARMA TRADING EUROPE EOOD - BULGARIA
  • Number: 12686/2019/01
  • Shelf life: 3 years

Concentrations available for olmesartan medoxomil

  • 10mg
  • 20mg
  • 40mg

Combinations with other substances